Noguchi, R.; Ono, T.; Sasaki, K.; Masuda, M.; Kawai, A.; Yoshimatsu, Y.; Kondo, T.
Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. Cells 2025, 14, 884.
https://doi.org/10.3390/cells14120884
AMA Style
Noguchi R, Ono T, Sasaki K, Masuda M, Kawai A, Yoshimatsu Y, Kondo T.
Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. Cells. 2025; 14(12):884.
https://doi.org/10.3390/cells14120884
Chicago/Turabian Style
Noguchi, Rei, Takuya Ono, Kazuki Sasaki, Mari Masuda, Akira Kawai, Yuki Yoshimatsu, and Tadashi Kondo.
2025. "Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans" Cells 14, no. 12: 884.
https://doi.org/10.3390/cells14120884
APA Style
Noguchi, R., Ono, T., Sasaki, K., Masuda, M., Kawai, A., Yoshimatsu, Y., & Kondo, T.
(2025). Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. Cells, 14(12), 884.
https://doi.org/10.3390/cells14120884